Jeffrey Allen Morris - 12 Aug 2024 Form 4 Insider Report for PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT)

Role
10%+ Owner
Signature
/s/ Jeffrey Allen Morris
Issuer symbol
PVCT
Transactions as of
12 Aug 2024
Net transactions value
+$756,467
Form type
4
Filing time
14 Aug 2024, 19:19:02 UTC
Previous filing
14 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PVCT Series D-1 Convertible Preferred Stock Conversion of derivative security $756,467 +264,314 +6.6% $2.86* 4,260,061 12 Aug 2024 Direct F3
holding PVCT Common Stock 12,000,000 12 Aug 2024 Direct F1
holding PVCT Common Stock 6,500,000 12 Aug 2024 By IRA F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person has sole voting and dispositive power over 12,000,000 shares of Common Stock.
F2 The reporting person has sole voting and dispositive power over 6,500,000 shares of Common Stock owned through an IRA retirement plan.
F3 The reporting person has sole voting and dispositive power over 4,260,061 shares of Series D-1 Convertible Preferred Stock, convertible into 42,600,610 shares of Common Stock.